Cambridge Cognition - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeCambridge Cognition
Cambridge Cognition logo

Cambridge Cognition

0 followers

COG

Performance

About Cambridge Cognition

Cambridge Cognition develops digital cognitive assessment technologies and tools for CNS clinical trials and healthcare research. The company offers an end-to-end platform including touchscreen cognitive assessments, voice analysis, electronic questionnaires, high-frequency testing, and decentralised clinical trial capabilities, used by pharmaceutical companies, research institutions, and clinicians worldwide. With over 30 years of scientific validation, its Cantab portfolio supports drug development, patient experience, and data management across multiple therapeutic areas. Headquartered in the United Kingdom, the organization focuses on neuroscience technology and cognitive assessment expertise for both academic research and clinical applications.

Recent News

No recent news for this company.

Recent Deals

No recent deals for this company.

Key Team Members

Nick Taptiklis

Head of R&D Technology

Francesca Cormack

Chief Scientist

Liam Kaufman

VP Corporate Business Development

Ricky Dolphin

Chief Technology Officer

Maria Yancheva

VP Technology

Key Facts

HQ Location

Cambridge, United Kingdom

Founded

2002

Employees

51 - 200

Status

Public

Website

https://cambridgecognition.com